-
公开(公告)号:US07893017B2
公开(公告)日:2011-02-22
申请号:US11664788
申请日:2005-10-07
申请人: Jesper Lau , Thomas Kruse Hansen
发明人: Jesper Lau , Thomas Kruse Hansen
IPC分类号: A61K38/26
CPC分类号: C07K14/605 , A61K38/00
摘要: Novel protracted GLP-1 compounds and therapeutic uses thereof.
摘要翻译: 新型长效GLP-1化合物及其治疗用途。
-
42.Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides 审中-公开
标题翻译: 新型结构定义的支化聚合物作为多肽共轭剂的合成与应用公开(公告)号:US20090240028A1
公开(公告)日:2009-09-24
申请号:US12276885
申请日:2008-11-24
申请人: Carsten Behrens , Florencio Zaragoza Dorwald , Mikael Kofod-Hansen , Jesper Lau , Janos Tibor Kodra , Thomas Kruse Hansen , Paw Bloch
发明人: Carsten Behrens , Florencio Zaragoza Dorwald , Mikael Kofod-Hansen , Jesper Lau , Janos Tibor Kodra , Thomas Kruse Hansen , Paw Bloch
IPC分类号: C07K14/00
CPC分类号: C12P21/005 , A61K47/549 , A61K47/60 , C12N9/6437
摘要: The invention provides synthesis and application of new structural well defined branched polymers as protraction agents for peptide and protein.
摘要翻译: 本发明提供新的结构明确的支化聚合物作为肽和蛋白质的助剂的合成和应用。
-
公开(公告)号:US20080249007A1
公开(公告)日:2008-10-09
申请号:US11664785
申请日:2005-10-07
申请人: Jesper Lau , Thomas Kruse Hansen
发明人: Jesper Lau , Thomas Kruse Hansen
CPC分类号: C07K14/57563 , A61K38/00
摘要: Novel protracted exendin-4 compounds and therapeutic uses thereof.
摘要翻译: 新型延长的毒蜥外泌肽-4化合物及其治疗用途。
-
公开(公告)号:US6127391A
公开(公告)日:2000-10-03
申请号:US218686
申请日:1998-12-21
申请人: Thomas Kruse Hansen , Bernd Peschke , Jesper Lau , Behrend Friedrich Lundt , Michael Ankersen , Brett Watson , Kjeld Madsen
发明人: Thomas Kruse Hansen , Bernd Peschke , Jesper Lau , Behrend Friedrich Lundt , Michael Ankersen , Brett Watson , Kjeld Madsen
IPC分类号: C07D333/20 , A61K31/00 , A61K31/17 , A61K31/18 , A61K31/216 , A61K31/27 , A61K31/38 , A61K31/381 , A61K31/41 , A61K31/4245 , A61K31/454 , A61K38/00 , A61K38/07 , A61K38/08 , A61P3/00 , A61P5/00 , A61P5/06 , A61P5/10 , A61P15/00 , A61P15/14 , A61P19/00 , B41J19/20 , C07C237/00 , C07C237/22 , C07C311/05 , C07C335/14 , C07D213/12 , C07D227/00 , C07D271/06 , C07D333/00 , C07D333/24 , C07D333/60 , C07D409/00 , C07D413/12 , C07K5/03 , C07K5/06 , C07K5/065 , C07K5/078 , C07K5/10 , C07K7/02 , C07K14/60 , A61K31/4439 , C07D401/12
CPC分类号: C07D271/06 , B41J19/205 , C07C237/22 , C07D333/24 , C07D413/12 , C07K5/0606 , C07K5/06078 , C07K5/06139 , C07K5/06191 , A61K38/00
摘要: Compounds of peptide mimetic nature having the general formula I ##STR1## wherein a and b are independently 1 or 2, R.sup.1 and R.sup.2 are independently H or C.sub.1-6 alkyl, G and J are independently, inter alia, aromats, and D and E are independently several different groups are growth hormone secretagogous with improved bioavailability.
摘要翻译: 具有通式I的肽模拟性质的化合物,其中a和b独立地为1或2,R 1和R 2独立地为H或C 1-6烷基,G和J独立地为芳族,D和E独立地为数个不同的 组是具有改善的生物利用度的促分泌素。
-
公开(公告)号:US6013658A
公开(公告)日:2000-01-11
申请号:US897239
申请日:1997-07-17
IPC分类号: C07D277/20 , A61K31/165 , A61K31/27 , A61K31/41 , A61K31/415 , A61K31/42 , A61K31/4245 , A61K31/425 , A61K31/426 , A61K31/4427 , A61K31/445 , A61K31/4465 , A61K38/00 , A61P43/00 , C07C233/38 , C07C237/22 , C07C237/32 , C07C237/36 , C07D211/60 , C07D211/62 , C07D257/04 , C07D271/06 , C07D271/10 , C07D277/56 , C07D401/12 , C07D413/12 , C07D417/12 , C07K5/065 , C07K14/60
CPC分类号: C07D271/06 , C07C233/38 , C07C237/22 , C07C237/32 , C07C237/36 , C07D211/62 , C07D271/10 , C07D277/56 , C07D401/12 , C07D413/12 , C07D417/12 , C07K14/60 , A61K38/00
摘要: There are disclosed novel synthetic peptides of formula (I) ##STR1## where A, B, D, E, F, G, J, m, n, and p are defined in the specification. Compounds of formula (I) promote the release of growth hormone in humans and animals. Growth promoting compositions containing such compounds of formula (I) as the active ingredient, methods of stimulating the release of growth hormone, and the use of such compounds of formula (I) are also disclosed.
摘要翻译: 公开了式(I)的新型合成肽,其中A,B,D,E,F,G,J,m,n和p在说明书中定义。 式(I)化合物促进人和动物中生长激素的释放。 还公开了含有式(I)化合物作为活性成分的生长促进组合物,刺激生长激素释放的方法,以及式(I)化合物的使用。
-
公开(公告)号:US09920106B2
公开(公告)日:2018-03-20
申请号:US13473154
申请日:2012-05-16
IPC分类号: A61K38/00 , A61P9/10 , C07K14/47 , C07K14/575 , C07K14/605
CPC分类号: C07K14/57563 , A61K38/00 , C07K14/605
摘要: Novel GLP-1 compounds and their therapeutic use.
-
公开(公告)号:US08603972B2
公开(公告)日:2013-12-10
申请号:US11908836
申请日:2006-03-20
IPC分类号: A61K38/26 , A61P3/10 , C07K14/605
CPC分类号: C07K14/605 , A61K38/00
摘要: The invention relates to protracted GLP-1 compounds and therapeutic uses thereof.
摘要翻译: 本发明涉及延长的GLP-1化合物及其治疗用途。
-
公开(公告)号:US20130053315A1
公开(公告)日:2013-02-28
申请号:US13427791
申请日:2012-03-22
申请人: Jesper Lau , Thomas Kruse Hansen , Kjeld Madsen , Paw Bloch , Florencio Zaragoza Dorwald , Nils Langeland Johansen
发明人: Jesper Lau , Thomas Kruse Hansen , Kjeld Madsen , Paw Bloch , Florencio Zaragoza Dorwald , Nils Langeland Johansen
IPC分类号: C07K2/00 , C07C235/74 , C07C237/22 , C07D251/54 , C07D207/416 , C07D209/26 , C07D333/68 , A61K38/26 , A61P3/10 , A61P3/04 , A61P9/12 , A61P3/06 , A61P25/00 , A61P9/10 , A61P1/04 , C07C309/17
CPC分类号: C07K14/605 , A61K38/00 , A61K38/26 , A61K47/54 , A61K47/542 , A61K47/60 , C07K14/001
摘要: Novel polypeptide derivatives having protracted profile of action.
摘要翻译: 新型多肽衍生物具有延长的作用特征。
-
公开(公告)号:US20100305032A1
公开(公告)日:2010-12-02
申请号:US12774131
申请日:2010-05-05
申请人: Jesper Lau , Thomas Kruse Hansen , Kjeld Madsen , Paw Bloch , Florencio Zaragoza Dorwald , Nils Langeland Johansen
发明人: Jesper Lau , Thomas Kruse Hansen , Kjeld Madsen , Paw Bloch , Florencio Zaragoza Dorwald , Nils Langeland Johansen
IPC分类号: A61K38/26 , C07K14/605 , A61P3/10
CPC分类号: C07K14/605 , A61K38/00 , A61K38/26 , A61K47/54 , A61K47/542 , A61K47/60 , C07K14/001
摘要: Novel polypeptide derivatives having protracted profile of action.
摘要翻译: 新型多肽衍生物具有延长的作用特征。
-
公开(公告)号:US20090054305A1
公开(公告)日:2009-02-26
申请号:US12282041
申请日:2007-03-15
CPC分类号: A61K38/28 , A61K9/0019 , A61K38/22 , A61K2300/00
摘要: The present invention relates to a soluble pharmaceutical composition for parenteral administration, which comprises an amylin peptide, and a meal-related insulin peptide, and to the use of such compositions for treatment of e.g. hyperglycemia.
摘要翻译: 本发明涉及用于肠胃外给药的可溶性药物组合物,其包含胰岛淀粉样多肽和胰蛋白酶相关的胰岛素肽,并且涉及使用这种组合物治疗例如胰岛素抵抗。 高血糖
-
-
-
-
-
-
-
-
-